WB
Western Blot analysis of various cells using VEGI Polyclonal Antibody. Secondary antibody was diluted at 1:20000IHC
Immunofluorescence analysis of HeLa cells, using TNFSF15 Antibody. The picture on the right is blocked with the synthesized peptide.| Product Name | VEGI Rabbit pAb |
|---|---|
| Antibody Type | Primary Antibodies |
| Immunogen | The antiserum was produced against synthesized peptide derived from human TNFSF15. AA range:181-230 |
| Clonality | Polyclonal |
|---|---|
| Isotype | IgG |
| Host Species | Rabbit |
| Tested Applications | ELISAIFWB |
| WB:1:500-1:2000 IF:1:200-1:1000 ELISA:1:20000 |
|
| Species Reactivity | HumanMouseRat |
| Concentration | 1mg/ml |
| Purification | Protein A |
| Gene Symbol | NCOA2 |
|---|---|
| Gene Synonyms | SRC2 TIF2 GRIP1 SRC-2 KAT13C NCoA-2 bHLHe75 |
| Gene Full Name | nuclear receptor coactivator 2 |
| Gene Summary | The protein encoded by this gene functions as a transcriptional coactivator for nuclear hormone receptors, including steroid, thyroid, retinoid, and vitamin D receptors. The encoded protein acts as an intermediary factor for the ligand-dependent activity of these nuclear receptors, which regulate their target genes upon binding of cognate response elements. This gene has been found to be involved in translocations that result in fusions with other genes in various cancers, including the lysine acetyltransferase 6A (KAT6A) gene in acute myeloid leukemia, the ETS variant 6 (ETV6) gene in acute lymphoblastic leukemia, and the hes related family bHLH transcription factor with YRPW motif 1 (HEY1) gene in mesenchymal chondrosarcoma. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2016] |
| Alternative Names | TNFSF15 TL1 VEGI Tumor necrosis factor ligand superfamily member 15 TNF ligand-related molecule 1 Vascular endothelial cell growth inhibitor |
| Molecular Weight(MW) | 20kD |
| Cellular Localization | Membrane,Secreted |
WB
Western Blot analysis of various cells using VEGI Polyclonal Antibody. Secondary antibody was diluted at 1:20000
IHC
Immunofluorescence analysis of HeLa cells, using TNFSF15 Antibody. The picture on the right is blocked with the synthesized peptide.| Application Notes | WB:1:500-1:2000 IF:1:200-1:1000 ELISA:1:20000 |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | -15°C to -25°C/1 year (Do not lower than -25°C) |
| Storage Buffer | Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide. |
